Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tift Mann

Showing results (21-30 of 50) with videos related to

Pageof 5
Sort By:
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
The American Journal of Cardiology|September 2, 1998
Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplastyJ E Burchenal, D S Marks, J Tift Mann, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Transradial approach for coronary angiography and interventions: results of the first international transradial practice surveyOlivier F Bertrand, Sunil V Rao, Samir Pancholy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2003
Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapyTift Mann, Roberto J Cubeddu, Laura Raynor, et al.
The American Journal of Cardiology|August 2, 2011
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stentsDean J Kereiakes, Louis A Cannon, John A Ormiston, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trialMark A Turco, Maurice Buchbinder, Jeffrey J Popma, et al.
Journal of Interventional Cardiology|July 14, 2010
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trialRobert D Safian, Michael R Jaff, John F Bresnahan, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trialsJiro Aoki, Gary S Mintz, Neil J Weissman, et al.
Coronary Artery Disease|December 13, 2012
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesionsJohn A Ormiston, O'Shaughnessy Charles, Tift Mann, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis, Gregg W Stone, David A Cox, et al.
Pageof 5

Showing results (21-30 of 50) with videos related to

Sort By:
Pageof 5
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
The American Journal of Cardiology|September 2, 1998
Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplastyJ E Burchenal, D S Marks, J Tift Mann, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Transradial approach for coronary angiography and interventions: results of the first international transradial practice surveyOlivier F Bertrand, Sunil V Rao, Samir Pancholy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2003
Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapyTift Mann, Roberto J Cubeddu, Laura Raynor, et al.
The American Journal of Cardiology|August 2, 2011
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stentsDean J Kereiakes, Louis A Cannon, John A Ormiston, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trialMark A Turco, Maurice Buchbinder, Jeffrey J Popma, et al.
Journal of Interventional Cardiology|July 14, 2010
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trialRobert D Safian, Michael R Jaff, John F Bresnahan, et al.
JACC. Cardiovascular Interventions|May 26, 2009
Chronic arterial responses to overlapping paclitaxel-eluting stents: insights from serial intravascular ultrasound analyses in the TAXUS-V and -VI trialsJiro Aoki, Gary S Mintz, Neil J Weissman, et al.
Coronary Artery Disease|December 13, 2012
Final 5-year results of the TAXUS ATLAS, TAXUS ATLAS Small Vessel, and TAXUS ATLAS Long Lesion clinical trials of the TAXUS Liberté paclitaxel-eluting stent in de-novo coronary artery lesionsJohn A Ormiston, O'Shaughnessy Charles, Tift Mann, et al.
JACC. Cardiovascular Interventions|February 5, 2010
Long-term safety and efficacy with paclitaxel-eluting stents: 5-year final results of the TAXUS IV clinical trial (TAXUS IV-SR: Treatment of De Novo Coronary Disease Using a Single Paclitaxel-Eluting Stent)Stephen G Ellis, Gregg W Stone, David A Cox, et al.
Pageof 5